View Author
Vugt, M.J. van
( M.J. van Vugt)
cpg b nk cells effect granulocyte effector antitumor tumor efficacy therapy effector cells depletion antibody cpg odn murine fc ri cpg odns cancer hfc ri antitumor activity activity immunol model study receptor lymphoma blood population expression antitumor effects effector cell populations antitumor effect -2/neu mechanism fc ri expression mdx-h hfc ri expression mouse combination winkel antibody therapy cpg motifs result experiment antibody efficacy monocyte bispecific response cell populations mdx-h 210 university mab therapy treatment tg mice igg 2a mab cytotoxicity nk cells decreases animal motif effector mechanisms fig krieg oligodeoxynucleotide antigen antitumor igg 1 class cytokine control tumor growth contrast weiner decrease coley factor production target immunostimulatory growth level breast impact valeriu
1 Most Recent Publications
|
CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations
(Article)
Ojik, H.H. van Bevaart, L. Dahle, C.E. Bakker, A. Jansen, M.J.H. Vugt, M.J. van Winkel, J.G. van de Weiner, G.J. |
2003-01-01
|
